Medicenna Therapeutics Corp (MDNA) — Cash Flow Quality Index

Latest as of March 2025: -4.21x

Medicenna Therapeutics Corp (MDNA) has a Cash Flow Quality Index of -4.21x as of March 2025. Operating cash flow of CA$-5.00 Million is below net income of CA$1.19 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Medicenna Therapeutics Corp (MDNA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-4.21x

Operating CF / Net Income

Operating Cash Flow

CA$-5.00 Million

CAD

Net Income

CA$1.19 Million

CAD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Medicenna Therapeutics Corp (None–None)

Year-by-year earnings quality comparison for Medicenna Therapeutics Corp.

Year	Quality Index	Operating CF (CAD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.